BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 35903330)

  • 1. From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases.
    Zhu Y; Xu P; Huang X; Shuai W; Liu L; Zhang S; Zhao R; Hu X; Wang G
    Front Pharmacol; 2022; 13():920113. PubMed ID: 35903330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic Strategy to Restore Adult Neurogenesis.
    Wang SN; Xu TY; Li WL; Miao CY
    CNS Neurosci Ther; 2016 Jun; 22(6):431-9. PubMed ID: 27018006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAMPT as a Therapeutic Target against Stroke.
    Wang P; Miao CY
    Trends Pharmacol Sci; 2015 Dec; 36(12):891-905. PubMed ID: 26538317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade.
    Zhao Y; Guan YF; Zhou XM; Li GQ; Li ZY; Zhou CC; Wang P; Miao CY
    Stroke; 2015 Jul; 46(7):1966-74. PubMed ID: 26060246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting NAMPT as a therapeutic strategy against stroke.
    Wang SN; Miao CY
    Stroke Vasc Neurol; 2019 Jul; 4(2):83-89. PubMed ID: 31338216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring NAD
    Katayoshi T; Nakajo T; Tsuji-Naito K
    J Photochem Photobiol B; 2021 Aug; 221():112238. PubMed ID: 34130091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
    Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J
    PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase.
    Zhang RY; Qin Y; Lv XQ; Wang P; Xu TY; Zhang L; Miao CY
    Anal Biochem; 2011 May; 412(1):18-25. PubMed ID: 21211508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives.
    Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X
    Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nicotinamide phosphoribosyltransferase protects against acute pancreatitis via modulating macrophage polarization and its related metabolites.
    He Y; Dai J; Niu M; Li B; Chen C; Jiang M; Wu Z; Bao J; Zhang X; Li L; Husain SZ; Hu G; Wen L
    Pancreatology; 2021 Aug; 21(5):870-883. PubMed ID: 33810973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide phosphoribosyltransferase regulates cocaine reward through Sirtuin 1.
    Kong J; Du C; Jiang L; Jiang W; Deng P; Shao X; Zhang B; Li Y; Zhu R; Zhao Q; Fu D; Gu H; Luo L; Long H; Zhao Y; Cen X
    Exp Neurol; 2018 Sep; 307():52-61. PubMed ID: 29753648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the NAD
    Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
    Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD
    Grolla AA; Miggiano R; Di Marino D; Bianchi M; Gori A; Orsomando G; Gaudino F; Galli U; Del Grosso E; Mazzola F; Angeletti C; Guarneri M; Torretta S; Calabrò M; Boumya S; Fan X; Colombo G; Travelli C; Rocchio F; Aronica E; Wohlschlegel JA; Deaglio S; Rizzi M; Genazzani AA; Garavaglia S
    J Biol Chem; 2020 Mar; 295(11):3635-3651. PubMed ID: 31988240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide phosphoribosyltransferase (Nampt) of hybrid crucian carp protects intestinal barrier and enhances host immune defense against bacterial infection.
    Tang Y; Liu X; Feng C; Zhou Z; Liu S
    Dev Comp Immunol; 2022 Mar; 128():104314. PubMed ID: 34785271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting NAMPT for Therapeutic Intervention in Cancer and Inflammation: Structure-Based Drug Design and Biological Screening.
    Pulla VK; Sriram DS; Soni V; Viswanadha S; Sriram D; Yogeeswari P
    Chem Biol Drug Des; 2015 Oct; 86(4):881-94. PubMed ID: 25850461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nampt and its potential role in inflammation and type 2 diabetes.
    Garten A; Petzold S; Schuster S; Körner A; Kratzsch J; Kiess W
    Handb Exp Pharmacol; 2011; (203):147-64. PubMed ID: 21484571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process.
    Khaidizar FD; Bessho Y; Nakahata Y
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue NAD
    Yamaguchi S; Franczyk MP; Chondronikola M; Qi N; Gunawardana SC; Stromsdorfer KL; Porter LC; Wozniak DF; Sasaki Y; Rensing N; Wong M; Piston DW; Klein S; Yoshino J
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23822-23828. PubMed ID: 31694884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.
    Revollo JR; Grimm AA; Imai S
    Curr Opin Gastroenterol; 2007 Mar; 23(2):164-70. PubMed ID: 17268245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.
    Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A
    J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.